Cognition Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	39.33	25.01	29.92	41.56	54.72	5.19
Cash & Short-Term Investments	39.33	25.01	29.92	41.56	54.72	5.19
Cash Growth	78.70%	-16.42%	-28.01%	-24.05%	954.56%	79.55%
Other Receivables	1.9	2.69	1.28	3.67	2.27	1.15
Receivables	1.9	2.69	1.28	3.67	2.27	1.15
Prepaid Expenses	1.16	1.86	3.02	2.41	2.01	0.54
Other Current Assets	-	-	-	-	-	0.02
Total Current Assets	42.88	29.56	34.22	47.65	58.99	6.91
Property, Plant & Equipment	0.51	0.68	0.94	1.05	0.15	0.21
Other Long-Term Assets	-	-	-	1.73	-	-
Total Assets	43.4	30.23	35.16	50.43	59.14	7.12
Accounts Payable	0.83	1.98	3.7	3.22	4.17	2
Accrued Expenses	3.92	7.62	4.05	2.09	1.75	0.99
Short-Term Debt	-	0.28	0.54	0.63	-	-
Current Portion of Leases	0.17	0.19	0.17	0.15	-	-
Current Unearned Revenue	1.74	1.07	1.7	1.7	0.75	-
Other Current Liabilities	-	-	-	-	1.19	0.25
Total Current Liabilities	6.65	11.14	10.17	7.8	7.86	3.25
Long-Term Debt	-	-	-	-	-	12.85
Long-Term Leases	0.21	0.34	0.52	0.7	-	-
Long-Term Unearned Revenue	-	-	-	1.69	-	-
Other Long-Term Liabilities	-	-	-	-	-	3.83
Total Liabilities	6.87	11.48	10.69	10.18	7.86	19.93
Common Stock	0.09	0.06	0.03	0.03	0.02	0
Additional Paid-In Capital	231.75	193.85	165.83	155.82	145.45	0.22
Retained Earnings	-195.3	-175.16	-141.19	-115.4	-94	-68.22
Comprehensive Income & Other	-	-	-0.2	-0.2	-0.2	-0.19
Total Common Equity	36.53	18.75	24.47	40.25	51.27	-68.18
Shareholders' Equity	36.53	18.75	24.47	40.25	51.27	-12.81
Total Liabilities & Equity	43.4	30.23	35.16	50.43	59.14	7.12
Total Debt	0.38	0.81	1.24	1.48	-	12.85
Net Cash (Debt)	38.95	24.2	28.68	40.08	54.72	-7.66
Net Cash Growth	81.77%	-15.65%	-28.44%	-26.75%	-	-
Net Cash Per Share	0.63	0.61	0.96	1.70	10.54	-15.08
Filing Date Shares Outstanding	88.27	61.97	39	29.26	22.58	0.54
Total Common Shares Outstanding	88.27	59.85	32.17	28.99	22.23	0.54
Working Capital	36.23	18.41	24.05	39.85	51.13	3.66
Book Value Per Share	0.41	0.31	0.76	1.39	2.31	-126.55
Tangible Book Value	36.53	18.75	24.47	40.25	51.27	-68.18
Tangible Book Value Per Share	0.41	0.31	0.76	1.39	2.31	-126.55
Machinery	-	1.34	1.33	1.19	1.02	0.99

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q